The RIMS1 Gene Cone-Rod Dystrophy Type 7 Genetic Test is a specialized diagnostic examination conducted at DNA Labs UAE, designed to detect mutations in the RIMS1 gene, which are implicated in the development of Cone-Rod Dystrophy Type 7 (CORD7). This rare genetic disorder affects the retina, leading to the progressive loss of vision starting with color vision and night vision, eventually advancing to a loss of peripheral vision and central vision. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any genetic anomalies associated with this condition. Early detection through this genetic testing can aid in the management and understanding of the disease, allowing for better planning for the affected individuals and their families.
The ADAM9 gene is linked to a form of inherited eye disorder known as Cone-Rod Dystrophy Type 9 (CORD9), which affects the retina and leads to progressive vision loss. This condition is characterized by the deterioration of cone and rod photoreceptor cells in the eye, crucial for color vision and seeing in low light, respectively. Symptoms often start with difficulty seeing in dim light and can progress to a loss of central and color vision.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the ADAM9 gene, providing crucial information for diagnosing Cone-Rod Dystrophy Type 9. This test is pivotal for individuals with a family history of the condition or those experiencing symptoms, as it can confirm the diagnosis and inform about the progression and management of the disease.
The cost of the ADAM9 gene test at DNA Labs UAE is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the ADAM9 gene. The results from this test can help in understanding the risk of developing the condition, guide treatment options, and support decisions regarding family planning for those affected by or carriers of the mutation.
The C21orf2 gene plays a significant role in the health and functionality of the retina, particularly influencing the development of cone-rod dystrophy, a genetic disorder that affects the eyes. Cone-rod dystrophy is characterized by the progressive loss of vision, starting with the deterioration of cone cells (responsible for color vision and visual acuity) and followed by rod cells (which enable low-light vision). Mutations in the C21orf2 gene have been identified as a causative factor for this condition, making genetic testing a valuable tool for diagnosis and understanding the risk of inheritance.
DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the C21orf2 gene, providing essential information for individuals with a family history of cone-rod dystrophy or those experiencing symptoms related to the disorder. The test is a critical step in the diagnosis process, offering insights that can guide treatment and management decisions, as well as inform family planning considerations.
The cost of the C21orf2 gene-related cone-rod dystrophy genetic test at DNA Labs UAE is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The process is designed to be as non-invasive and straightforward as possible, with results typically available within a few weeks. The outcome of the test can provide individuals and their healthcare providers with crucial information to better understand the condition, its progression, and potential interventions to manage symptoms and improve quality of life.
The GCNT2 gene cataract autosomal dominant genetic test is a specialized diagnostic tool designed to identify mutations in the GCNT2 gene, which are associated with a form of cataract inherited in an autosomal dominant manner. Cataracts, characterized by the clouding of the eye's lens, can lead to diminished vision and, if untreated, blindness. The specific mutations in the GCNT2 gene linked to this condition can result in an early onset of cataract development, distinguishing it from age-related cataracts.
This genetic test is crucial for families with a history of early cataract development, as it helps in the early detection and management of the condition. Early diagnosis can lead to timely interventions, potentially preserving vision and improving the quality of life for affected individuals. Moreover, understanding the genetic basis of the condition can provide valuable information for family planning and genetic counseling.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, offering a comprehensive range of genetic testing services. The cost of the GCNT2 gene cataract autosomal dominant genetic test is 4400 AED. This price reflects the intricate processes involved in genetic analysis, including DNA extraction, amplification, and sequencing, which are necessary to accurately identify mutations in the GCNT2 gene.
By opting for this test at DNA Labs UAE, individuals and families gain access to state-of-the-art genetic testing technologies, expert interpretation of results, and personalized advice on managing and mitigating the risks associated with hereditary cataracts.
The "CRYBB3 Gene Cataract Autosomal Recessive Congenital Nuclear Type 2 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the CRYBB3 gene that are associated with the development of a specific type of cataract. This condition, known as autosomal recessive congenital nuclear cataract type 2, is characterized by the clouding of the eye's lens at birth or shortly thereafter, affecting vision. The test is critical for early diagnosis and management of the condition, facilitating personalized treatment plans and potentially preventing severe vision impairment.
The genetic test involves analyzing the patient's DNA to identify mutations in the CRYBB3 gene, which plays a crucial role in the development and maintenance of lens transparency in the eye. Identifying mutations in this gene can confirm the diagnosis and help in understanding the inheritance pattern within a family, offering insights into the risk for future offspring.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test represents a significant step forward in the early detection and management of congenital cataract conditions, offering hope and improved outcomes for affected individuals and their families.
The "CRYAA Gene Cataract Autosomal Recessive Congenital Type 1 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE. This test specifically targets the CRYAA gene, which plays a crucial role in the development of the eye's lens. Mutations in the CRYAA gene can lead to autosomal recessive congenital cataracts, a condition characterized by clouding of the lens at birth or shortly thereafter, potentially resulting in significant visual impairment or blindness if not diagnosed and treated promptly.
The genetic test is designed to detect mutations within the CRYAA gene, providing essential information for accurate diagnosis and guiding treatment decisions. By identifying the genetic underpinnings of the condition, the test can also offer valuable insights into the risk of recurrence in future pregnancies, assisting families in making informed reproductive choices.
Priced at 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost reflects the sophisticated technology and expertise required to accurately identify mutations in the CRYAA gene. This test is a vital resource for families affected by congenital cataracts, offering hope for early intervention and the potential for better visual outcomes.
The "FYCO1 Gene Cataract Autosomal Recessive Congenital Type 2 Genetic Test" is a specialized diagnostic examination designed to detect mutations in the FYCO1 gene, which are linked to the development of Autosomal Recessive Congenital Cataracts Type 2 (ARCC2). This condition is a rare, hereditary eye disorder that manifests from birth or early childhood, leading to clouding of the lens in the eye and potentially severe visual impairment or blindness if not diagnosed and managed appropriately.
The test is crucial for families with a history of this condition, as it aids in early detection, allowing for timely intervention and management strategies to preserve vision. It involves analyzing the patient's DNA to identify mutations in the FYCO1 gene, which plays a significant role in lens development and clarity. By pinpointing these genetic alterations, healthcare providers can confirm a diagnosis of ARCC2, guide treatment decisions, and offer genetic counseling to affected families.
Offered by DNA Labs UAE, the test cost is 4400 AED. DNA Labs UAE is equipped with advanced genetic testing facilities and expertise, ensuring high accuracy and reliability of the test results. This test is an important tool in the field of genetic ophthalmology, offering hope and crucial information for individuals and families grappling with the challenges of congenital cataracts.
The "TDRD7 Gene Cataract Autosomal Recessive Congenital Type 4 Genetic Test" is a specialized diagnostic examination designed to identify mutations in the TDRD7 gene, which are linked to the development of autosomal recessive congenital cataracts type 4. This condition is characterized by the clouding of the lens in the eye that is present from birth or develops shortly after, leading to impaired vision. As an autosomal recessive disorder, an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test is crucial for early diagnosis, which can significantly impact the management and treatment strategies for affected individuals, potentially improving their quality of life. It is also valuable for genetic counseling, offering families insight into their risk of passing the condition onto future generations.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the intricate processes involved in genetic sequencing and analysis. By opting for this test, individuals gain access to critical information that can guide medical and personal decisions regarding a condition that significantly affects vision from a very early age.
The AGK Gene Cataract Autosomal Recessive Type 38 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the AGK gene, which have been associated with the development of autosomal recessive cataract type 38. Cataracts related to mutations in the AGK gene typically present early in life and can significantly impact vision quality and development if not diagnosed and managed appropriately.
The test is crucial for families with a history of this condition, as it provides essential information for genetic counseling, early intervention, and personalized management strategies to mitigate the impact of the disease. The procedure involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the AGK gene.
The cost of the AGK Gene Cataract Autosomal Recessive Type 38 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test, it represents a critical investment in the health and well-being of individuals at risk for this rare form of cataract, enabling timely and effective treatment decisions.
The "SORD Gene Cataract Congenital Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying congenital cataracts linked to mutations in the SORD gene. Congenital cataracts, which can appear in newborns or develop in early childhood, are primarily characterized by the clouding of the eye's lens, potentially leading to vision impairment or blindness if not timely addressed. The SORD gene, implicated in various metabolic pathways, has been associated with this specific type of cataract, making its examination crucial for early detection and management.
DNA Labs UAE offers this cutting-edge genetic test for a cost of 4400 AED. The test is designed to provide precise and reliable results, enabling healthcare providers to develop personalized treatment plans for affected individuals. By identifying the genetic mutation early, interventions can be more effectively tailored to prevent the progression of vision loss and improve the quality of life for those diagnosed with this condition. This test is an essential tool in the arsenal against congenital cataracts, offering hope and solutions to families dealing with this challenging diagnosis.
